Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZSCAN2 antisense RNA 1 (ZSCAN2-AS1)
- Target
- ZSCAN2-AS1
- Molecular classification
- Long non-coding RNA, Antisense RNA, Non-coding RNA, Other
01
Overview
ZSCAN2 antisense RNA 1 (ZSCAN2-AS1) is a long non-coding antisense RNA transcript that is complementary to the ZSCAN2 genomic locus. It is classified as an antisense RNA and does not code for a protein. As with other long non-coding antisense RNAs, ZSCAN2-AS1 is believed to play a regulatory role in gene expression, potentially influencing chromatin architecture, regulating transcription of its sense counterpart, and possibly participating in post-transcriptional regulation through RNA-RNA or RNA-protein interactions. However, there is currently no evidence that ZSCAN2-AS1 is a protein-coding therapeutic target, nor are there specific functional or disease associations, interacting drugs, or known biomarker roles documented for this gene[1][2][3][5].
- Other names
- AC048382.5LOC105370947
02
Biological functions
Regulation of gene expressionEpigenetic modificationPost-transcriptional regulationChromatin architecture regulation
03
Disease associations
Other (no disease associations or functional disease roles have been reported in the provided sources for ZSCAN2-AS1 specifically)
Beyond the preview
Go deeper on ZSCAN2 antisense RNA 1 (ZSCAN2-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ZSCAN2 antisense RNA 1 (ZSCAN2-AS1).